Loading...
•
Dec 31, 2020
AdaptHealth Q4 2020 Earnings Report
AdaptHealth reported strong Q4 2020 financial results, driven by growth in the diabetes business and accretive acquisitions.
Key Takeaways
AdaptHealth Corp. announced financial results for the fourth quarter and full year ended December 31, 2020. The company is increasing its previously issued financial guidance for fiscal year 2021.
Diabetes business drove substantial growth due to high ordering patterns in December.
Continued investment in accretive acquisitions contributed to growth.
Increased guidance for 2021 due to acquisitions and organic growth prospects.
Integration of AdaptHealth and AeroCare is progressing smoothly, with a focus on achieving cost synergies and enhancing organic growth.
Forward Guidance
The Company is increasing its previously issued financial guidance for fiscal year 2021.
Positive Outlook
- Acquisitions
- Organic growth in 2021
- Underlying growth in the diabetes business
- Investments in chronic disease businesses such as obstructive sleep apnea
- Enhanced scale of the combined AdaptHealth and AeroCare
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...